Cash-flow figures use the latest fiscal year: this filer tags quarterly cash flows year-to-date only and the missing discrete quarters could not be derived (irregular fiscal quarters or a tagging change), so no four consecutive quarters exist to sum.
No four consecutive quarters could be summed for EPS (Diluted); these figures use the latest fiscal year, not a trailing twelve months.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
193.20×
118.44×
63rd
+0.12σ
24.86×
127 · 127
2.4%
4.6%
22nd
−0.80σ
−36.9%
127 · 11
2.3%
6.2%
9th
−0.92σ
−15.4%
127 · 12
6.6%
11.2%
20th
−0.73σ
−21.3%
138 · 12
25.1%
12.3%
46th
−0.38σ
5.1%
141 · 141
−35.7%
15.5%
4th
−1.55σ
8.4%
92 · 8
−2.7%
32.4%
3rd
−1.91σ
9.0%
103 · 9
Market Cap
$9.38B
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
Own median 118.44× × $0.86 = $101.86vs the $176.36 close · earnings held constant
Own multiple
P/E
Implied price
vs close
10th percentile
54.82×
$47.15
−73.3%
25th percentile
83.75×
$72.03
−59.2%
median
118.44×
$101.86
−42.2%
75th percentile
224.91×
$193.43
+9.7%
90th percentile
264.64×
$227.59
+29.0%
today
205.07×
$176.36
—
Reference computation · 127 monthly P/E observations in Full · EPS basis FY2025 EPS (Diluted) $0.86 · close $176.36 (2026-08-19)ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
Covered pool$977.78B +7.6%/yr 2020→2025Concentration484 of 10,000fragmented · top 3 hold 22.9% · −24 pts since 2020RGEN0.1% · rank 65 of 348 · +0.0pp over 5y· CV 0.44 · σ 0.0pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace0.1% → 0.0%
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
RGEN share over timelast 6 of 10 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
coverage: 321 of the 385 members that…
Share of covered industry revenue · n=348 in Pharmaceuticals & Biotechnology · CY2025 pool · built 2026-08-19 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
